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His(trt)和 Lys(Boc)；接肽反应以 DMF 为反应溶剂, N-羟基苯并三唑 (HOBt) , 
N,N-二环己基碳二酰亚胺 (DCC) 为复合缩合剂，三氟乙酸（TFA）切除保护基
团。各步反应经 TLC 跟踪和旋光分析， 终产物进行色谱分析和质谱鉴定。实
验结果表明，在对温度、原料配比、反应时间的控制下，以 HOBt/DCC/DIEA 进
行接肽反应、用三氟乙酸（TFA）脱除叔丁氧羰基（Boc）是一种可行的方法。
实验中各步产率均在 30%以上，ESI 质谱测得的 m/z 与理论值相符。活性测定结
果表明产物具有一定生物活性。 
Eptifibatide是一种血小板糖蛋白GPⅡb／Ⅲa受体拮抗剂，临床研究结果显示





























Peptide is a type of bioactive substance that participates in normal functioning of 
a living organism. Isolation and purification of the peptide from natural sources has 
not been very successful; the use of recombinant DNA techniques has a problem of 
lower yield; so, chemical synthesis of peptide in the laboratory appears to be an 
efficient method. In this thesis, the tripeptide GHK has been synthesized by 
liquid-phase method and octpeptide Eptifibatide by solid-phase method. Coupling 
agents and purification problem have been studied in the process of peptide synthesis. 
GHK is a tripeptide found in normal human plasma. It was found to accelerate 
growth in cultured cells and tissues e.g. fibroblasts, macrophages. GHK has been 
synthesized by liquid-phase method in this thesis. The amino of Glycine, the 
imidazole of Histidine and the ε-amino of Lysine were protected, gaining the 
intermediates: Boc-Gly, His(trt), Lys(Boc); DMF is used as the coupling solvent; 
HOBt and DCC as the coupling agents; TFA to removed the protecting group. 
Products were confirmed by TLC and polarimetric analysis. The synthetic product 
was identified on ESI-MS and HPLC. The experimental data indicated that under the 
control of temperature, material ratio and reaction time, using HOBt/DCC/DIEA for 
coupling, TFA for deprotection of Boc might be a good way of liquid-phase peptide 
synthesis. The result shows that the yield of each reaction is over 55 %. The molecular 
weight of the product is correspond to molecular weight of the GHK. The results of 
bioactivity identification indicated that GHK has bioactivity on certain degree.  
Eptifibatide is the receptor antagonist of platelet glycoprotein GP b/ aⅡ Ⅱ , 
Clinical study showed that it has the advantage of potent effect. In this thesis, a 
strategy for the synthesis of Eptifibatide was presented. Eptifibatide has been 
synthesized by solid - phase method using the base-labile Fmoc group for protecting 
the α-amino acid. The peptide was assembled on Rink-Am-Resin. TBTU/HOBt/DIEA 
is used as the activation system; and TFA/EDT/TIS/H2O as the cleavage condition. 

















liquid chromatography and identified on MALDI-TOF-MS and HPLC. The 
experimental result shows that the ratio of the coupling synthesis of each amino acid 
is over 95 %. The final purity of our product was found more than 98.5%. The 
molecular weight of the product is correspond to molecular weight of the Eptifibatide. 
 
 











































分子量在 180～1000 dalton 之间的称为小肽、寡肽、低聚肽，也称为小分子活性
























































化学家 Max Bergman 和 Leonidas Zervas 发明了用氨基酸合成人工多肽的技术，













残基的方法合成了四肽 Leu-Ala-Gly-Val[12]。Merrifield 建立的经典的 Boc 固相法
[13]得到广泛应用，一些生物大分子，如生长因子等，被成功的合成出来。Merrifield
由此获得 1984 年诺贝尔化学奖。1978 年，Chang，Meienlofer 和 Atherton 等人采
用 Fmoc 作为保护基，发展出 Fmoc 固相法[13]，相比 Boc 固相法来说反应条件更
温和，步骤也更简便。由此得到了越来越多的应用。目前，国内外用 Fmoc 法成





















一样，并在有机溶剂中具有可溶性。 早采用片段缩合法的是 Omenn G 等人[17]，
先用液相法合成出全保护的四肽酸，再与二肽树脂缩合，得到 90％的纯的六肽；

































图 1.1 肽键形成简图 

























































































赖氨酸的 ε-氨基原则上也可用保护 α-氨基的保护基团，其 早使用的是对
甲苯磺酰基（Tos），如 Lys（Tos）曾成功的用于催产素，加压素，胰岛素等多肽、















































图 1.2 形成酰胺键的通式 
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